The removal of the 25% fentanyl-related US tariffs would not transform the outlook for the Canadian economy, which would still suffer due to the impact of other tariffs and general uncertainty over the future of Canada’s trading relationship with the US.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services